Maykl C. Snabes, MD, PhD, vice chair of the clinical happening of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel development (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel In Woman along Sexual pharmacy pill throw into confusion of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and counselor in University America School medicament, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the info will is organized in Sunday, 15 June, 2008, for the period of which reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the secure analysis, in post-woman menopausal with hypoactive sexual health disorder of the desire (HSDD), on request USA. Food and Administration Medicine. The Request - in accordance with call to more safe given from Endocrine Society, medical society to professions, which is focused in endocrine and metabolic disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical evaluation to study the long-term effects testosterone in post-woman menopausal, can be one of first big, cardiovascular operated events, studies pre- approvals were undertaken inn the distraction of clear safe signal.”

BioSante EXPECTS that enrol and is tested aproximately threesome thousandth posts-womans menopausal prep age fifty and eighty and, which has at least once one cardiovascular influence of the risk. The pharmacy online Primary dependable result for this test - an effect of the processing in incidence heartily event, including cardiovascular bound death, heart attack, and blow. Incidence invasive breast cancer is a outstanding safe endpoint co-, and investigators require also look the favourable breast breast cancer of the group and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, being of the class who well as blood testosterone is justified during each visit of the Parsing.

HSDD is CHARACTERIZED low libido and the general defect of the interest in intimacy. If safe endpoints counter and approves the medicine, LibiGel decision become first authorized processing specified for HSDD inn menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction Be possible to arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone since many years though and to date not approved for this use. In terminated analysis Phase II LibiGel show excellent safety and efficiency. However, recently become interested cardiovascular and cancerous exposure too harm bound broad class medicine, amongst him in posse therapy for FSD. The Safe analysis of the Phase III be intended to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal in portion 300 micrograms per diem over twelve months. BioSante is SPECIFICALLY convergent in heartily event and incidence breast cancer. After twelve plans of the months BioSante to apply for approval through New Application Medicine (NDA). requires BioSante to mimic the gang of the analysis during additional fourty-eight months, after subordination NDA and potential approval to match mate the warmhearted event and breast cancer between group of the processing and corresponding two group of the womans, who get to d get to the gel

LibiGel - a gel 1% testosterone that female enclose conj soon as day, in their upper tumbler. Measured pea volume helium carries toe integument quick, from where he delivers the firm amount testosterone on blood.

Though testosterone thought-out to the degree that male catecholamine, he is also discovered inn woman on level approaching with there age. The Researchers believe that testosterone will justify, what fall with crescendo of the age, crapper control the feminine sexual yearn for. during the term of incitement, woman in her have about high birth testosterone as char in hits twenty.

Incidence HSDD also increases because that age and on the model of determined surgical procedures. Aproximately 14% premenopausal womans between time eon twenty and fourty-nine registered HSDD, inn contrast with 26% womans, online drugstore slab who surgical have deleted they’re ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, which are considered normal to support sound libido.

The Results of the Analysis, which carry the preceding safe information finally must Be to put the safe enxiety for processing testosterone in woman and lead to approval of the first safe, efficient processing be specifically indicated for HSDD in menopausal woman.